Related Experiment Video

Updated: Jul 20, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

A1 adenosine receptors in microglia control glioblastoma-host interaction

Michael Synowitz1, Rainer Glass, Katrin Färber

  • 1Cellular Neuroscience Group, Max Delbrück Center for Molecular Medicine, Berlin, Germany.

Cancer Research
|September 5, 2006
PubMed

Insights

Adenosine receptor A(1) (A(1)AR) deficiency accelerates glioblastoma growth by increasing microglial accumulation. Adenosine attenuates glioblastoma growth by acting via A(1)AR in microglia, highlighting a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Cancer Biology
  • Immunology

Background:

  • Glioblastoma is an aggressive brain tumor with limited treatment options.
  • The role of adenosine signaling and microglial cells in glioblastoma progression is not fully understood.

Purpose of the Study:

  • To investigate the role of the adenosine receptor A(1) (A(1)AR) in glioblastoma growth.
  • To elucidate the interaction between A(1)AR, microglia, and tumor progression.

Main Methods:

  • Glioblastoma growth was studied in A(1)AR-deficient mice and organotypical brain slice cultures.
  • Immunocytochemistry was used to detect A(1)AR expression in microglia from mice and human glioblastoma.
  • Microglial cells were depleted in brain slice cultures to assess their role.

Main Results:

  • Glioblastoma grew more vigorously in A(1)AR-deficient mice, with increased microglial accumulation around tumors.
  • A(1)AR was highly expressed in microglia associated with tumors in mice and humans.
  • A(1)AR agonists suppressed glioblastoma growth in brain slices, but stimulated it when microglia were depleted.

Conclusions:

  • Adenosine attenuates glioblastoma growth by acting through A(1)AR expressed in microglia.
  • Targeting the A(1)AR-microglia axis may offer a novel therapeutic strategy for glioblastoma.

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...